What Causes ALT to Be Out of Range?

What Causes ALT to Be Out of Range?

For most people, elevated ALT means the liver is under stress — most often from excess fat accumulation, insulin resistance, or a medication the liver is working hard to clear. The main caveat: "in range" does not mean optimal; many researchers now argue that a truly healthy ALT sits below 25–30 U/L for women and below 35 U/L for men. The exception is intense resistance exercise, which can spike ALT transiently without any liver pathology.

---

What ALT Actually Measures — and Why the Reference Range Misleads You

Alanine aminotransferase is an enzyme found predominantly in hepatocytes (liver cells). When those cells are damaged, inflamed, or simply overloaded, ALT leaks into the bloodstream. Most commercial labs flag ALT above 40–56 U/L as high, but these cutoffs were derived from population samples that included individuals with undiagnosed metabolic disease — so "normal" is statistically average, not biologically ideal.

A landmark reanalysis published in Annals of Internal Medicine found that when the reference population was restricted to metabolically healthy, non-obese non-drinkers, the upper limit of normal for ALT dropped to roughly 30 U/L in men and 19 U/L in women (Prati et al., Ann Intern Med 2002; PMID: 12144115). That single finding reshuffled how functional-medicine practitioners read liver panels.

Always read ALT alongside AST, GGT, ALP, and bilirubin for a complete hepatic picture. An isolated ALT elevation with normal GGT, for example, points more toward muscle than liver as the source.

---

Fatty Liver Root Causes: Why NAFLD Is the Leading Driver of Elevated ALT

Nonalcoholic fatty liver disease (NAFLD) is now the most common cause of chronically elevated ALT in developed countries, affecting an estimated 25% of the global adult population (Younossi et al., Hepatology 2016; PMID: 26707365). When the liver accumulates fat exceeding 5% of its weight, hepatocytes become inflamed and begin releasing ALT at rates that outpace the liver's repair capacity.

The fatty liver root cause cascade typically looks like this:

1. Excess dietary fructose and refined carbohydrates drive de novo lipogenesis — the liver converts surplus sugar into triglycerides faster than it can export them.
2. Hyperinsulinemia suppresses fatty acid oxidation, trapping fat inside hepatocytes. If you've had a fasting insulin panel run alongside your liver enzymes, it's worth understanding what causes fasting insulin to be out of range — the two biomarkers often rise together.
3. Visceral adiposity floods the liver with free fatty acids via the portal vein, compounding fat deposition.
4. Gut dysbiosis increases hepatic exposure to lipopolysaccharide (LPS), a bacterial endotoxin that triggers Kupffer cell activation and liver inflammation.

Importantly, NAFLD-driven ALT elevation frequently coexists with abnormal lipid markers. If your triglycerides are also high, the functional-medicine guide to what causes triglycerides to be out of range explains how these two panels reinforce each other as metabolic warning signals.

---

Prediabetes Root Causes and Their Direct Connection to ALT

Insulin resistance and early glucose dysregulation are deeply intertwined with hepatic enzyme elevation. The liver is central to glucose homeostasis — it stores glycogen, releases glucose during fasting, and converts amino acids to glucose via gluconeogenesis. When insulin signaling breaks down, all three pathways misfire simultaneously.

A prospective study following more than 11,000 adults found that even mildly elevated ALT (above the sex-specific median) was associated with a 2- to 3-fold increased risk of developing type 2 diabetes over 5 years, independent of BMI and conventional risk factors (Hanley et al., Diabetes Care 2005; PMID: 15793207). The mechanism: hepatic inflammation directly impairs insulin receptor signaling inside the liver, creating a feedback loop where insulin resistance worsens fat accumulation, which worsens inflammation, which elevates ALT further.

This is why prediabetes root causes and fatty liver root causes overlap so heavily:

• Chronically elevated cortisol (from poor sleep, psychological stress, or HPA axis dysregulation) drives visceral fat deposition and gluconeogenesis simultaneously.
• Low skeletal muscle mass reduces peripheral glucose disposal, pushing more glucose toward hepatic processing.
• Sedentary behavior blunts GLUT4 translocation in muscle, forcing glucose into hepatic lipogenic pathways.

If you're tracking ALT alongside glucose markers, pairing your panel with an ApoB result adds even more context — understanding what causes ApoB to be out of range can reveal whether the liver is overproducing atherogenic lipoproteins as a downstream consequence of the same insulin-resistance pattern.

---

Medications, Supplements, and Substances That Raise ALT

The liver metabolizes almost every compound that enters the body. When metabolic demand exceeds hepatic capacity — or when a drug or supplement is directly hepatotoxic — ALT rises as a distress signal.

Common pharmaceutical drivers:

• Statins: Mild ALT elevations occur in 1–3% of statin users; clinically significant hepatotoxicity is rare but requires monitoring.
• NSAIDs (ibuprofen, naproxen): Chronic use causes dose-dependent hepatocellular stress.
• Acetaminophen: Even within "safe" doses, daily acetaminophen over months depletes hepatic glutathione reserves and raises ALT, particularly in individuals who also drink alcohol.
• Metformin: Generally liver-protective in NAFLD, but can occasionally elevate ALT in the first weeks of use.
• Oral contraceptives: Affect hepatic cholesterol and enzyme metabolism; cholestatic ALT elevation is documented.

Supplement-related causes are underappreciated. A systematic review identified green tea extract, high-dose vitamin A, kava, and bodybuilding supplements (particularly those containing DMAA or anabolic steroid precursors) as documented hepatotoxic agents (Navarro et al., Hepatology 2014; PMID: 24798002). "Natural" does not mean liver-safe at high doses.

Alcohol warrants its own mention: even moderate drinking (>14 drinks/week in men, >7 in women) measurably elevates ALT, and the AST:ALT ratio typically exceeds 2:1 in alcohol-related liver disease — a clinically useful distinguishing pattern.

---

Less Obvious Causes: Thyroid, Celiac, and Muscle Injury

When the obvious metabolic and medication causes have been ruled out, clinicians pivot to a second-tier differential:

Hypothyroidism: Thyroid hormones regulate hepatic lipid oxidation and protein synthesis. Hypothyroid states slow hepatic metabolism, leading to fat accumulation and ALT elevation that normalizes with thyroid hormone replacement. ALT should always be interpreted with TSH when hypothyroidism is suspected.

Celiac disease: Gluten-triggered intestinal inflammation increases gut permeability, allowing LPS and immune complexes to reach the liver through the portal circulation. Approximately 40% of untreated celiac patients have elevated liver enzymes; most normalize on a strict gluten-free diet.

Vigorous resistance exercise: Muscle cells contain ALT, though at lower concentrations than hepatocytes. A heavy squat session can raise ALT by 10–30 U/L within 24 hours and keep it elevated for 3–5 days. If your elevated result was drawn shortly after a hard workout, repeat the panel after a 5-day rest window before pursuing hepatic workup.

Hemochromatosis: Iron overload directly damages hepatocyte mitochondria. Elevated ALT with elevated ferritin and transferrin saturation should prompt genetic testing for HFE mutations.

---

Longevity Root Causes: Why ALT Is a Marker Beyond the Liver

One of the most striking reframings in longevity medicine is the recognition that ALT is not just a liver-specific marker — it is a systemic metabolic health signal. Population studies consistently show that ALT in the lower half of the reference range predicts better long-term outcomes across multiple organ systems.

A large European cohort study (EPIC) found that ALT above 30 U/L was independently associated with increased all-cause mortality, even after excluding individuals with known liver disease, diabetes, and heavy alcohol use (Kunutsor et al., J Hepatol 2014; PMID: 24768851). The researchers proposed that ALT captures a global state of metabolic inflammation — which tracks with longevity root causes including mitochondrial dysfunction, chronic low-grade inflammation, and impaired autophagy.

For those optimizing for longevity rather than merely avoiding disease, an ALT below 25 U/L (alongside low-normal GGT, healthy fasting insulin, and controlled inflammatory markers like hs-CRP) is a reasonable functional target. This is also why cardiovascular risk markers cluster with liver enzymes — if you've also seen your cholesterol ratio out of range, the underlying metabolic inflammation may be the common thread.

---

How to Actually Lower ALT: Evidence-Based Interventions

Once reversible causes (medications, alcohol, recent exercise) have been excluded, the most effective interventions for metabolic ALT elevation are:

1. Caloric deficit and weight loss

Meta-analyses consistently show that losing 5–10% of body weight reduces ALT by 20–40 U/L in NAFLD patients. The mechanism is primarily reduced hepatic fat content.

2. Low-glycemic dietary pattern

Replacing refined carbohydrates and fructose-sweetened beverages with whole foods reduces de novo lipogenesis and lowers ALT independently of total calorie intake.

3. Aerobic exercise

A 2017 meta-analysis found that 150+ minutes per week of moderate aerobic exercise reduced ALT by an average of 7.2 U/L in NAFLD patients, even without significant weight loss (Golabi et al., Hepatology 2016; PMID: 27003146). Exercise improves hepatic fat oxidation through AMPK activation.

4. Alcohol reduction or elimination

In alcohol-related ALT elevation, abstinence for 4–8 weeks typically normalizes enzyme levels if cirrhosis has not developed.

5. Management of underlying insulin resistance

Addressing the root cause of hepatic fat deposition — insulin resistance — is the most durable strategy for sustained ALT normalization.

---

What This Means for Your Formula

Liver health sits at the intersection of multiple body systems, and a targeted supplement strategy needs to reflect that complexity rather than reach for a generic "detox" formula.

Ones Liver Support Blend is a proprietary system blend formulated specifically for hepatic function. Rather than isolated milk thistle, it combines multiple botanicals and cofactors at clinically relevant doses to support phase I and phase II detoxification pathways, hepatocyte membrane integrity, and antioxidant defense within the liver itself.

Omega-3 (EPA/DHA) is one of the most studied individual ingredients for NAFLD. A meta-analysis of 10 randomized controlled trials found that omega-3 supplementation significantly reduced liver fat content, ALT, and AST in NAFLD patients (Yan et al., J Clin Endocrinol Metab 2018). Ones includes EPA/DHA dosed to the clinical range used in these trials, calibrated to each person's intake from diet and wearable-reported activity level.

CoQ10/Ubiquinol at 200mg supports hepatic mitochondrial function — relevant because NAFLD progression correlates strongly with mitochondrial electron transport chain dysfunction. When the AI analysis at Ones identifies metabolic markers consistent with early hepatic stress (elevated ALT + elevated fasting insulin + triglycerides above optimal), CoQ10 as ubiquinol is a frequently included active because the liver's capacity to convert CoQ10 to its active form declines under oxidative stress.

What makes this clinically meaningful is personalization: someone whose ALT is elevated primarily from a high-intensity training program needs a different response than someone whose ALT tracks alongside a borderline fasting glucose and an expanding waist circumference. The Ones AI draws on blood work, wearable activity data, and health history to distinguish those patterns before building a formula — rather than defaulting to a one-size liver stack.

---

Key Takeaways

• The standard lab reference range for ALT is too permissive. Functional optimal is below 30–35 U/L for men and below 25 U/L for women; values above these levels warrant investigation even if flagged "normal."
• NAFLD driven by insulin resistance and excess dietary carbohydrate is the most common cause of chronically elevated ALT in otherwise healthy adults.
• Medications and supplements are underappreciated hepatotoxic triggers — acetaminophen, NSAIDs, statins, high-dose vitamin A, and green tea extract are the most clinically significant.
• Intense resistance exercise can raise ALT transiently by 10–30 U/L without any liver pathology; always repeat a post-workout result after a 5-day rest before pursuing workup.
• ALT is a longevity biomarker, not just a liver marker — population studies link even mildly elevated ALT to increased all-cause mortality independent of known liver disease.
• Sustainable ALT reduction requires treating the root cause: weight loss, dietary quality, aerobic exercise, alcohol reduction, and insulin resistance management outperform any supplement used in isolation.